Moreover, previous epidemiological studies have reported that increased binding of vitamin D to VDR is associated with decreased RCC risk, and that active levels of vitamin D3 in serum are significantly lower in RCC patients compared to population controls [15], [16], [19]. The gene discussed is VDR; the disease is renal cell adenocarcinoma.